Late-stage diagnosis of HIV infection in Brazilian children: Evidence from two national cohort studies;Diagnóstico tardio da infecção por HIV em crianças brasileiras: Evidências baseadas em dois estudos nacionais de coorte

Cadernos de Saude Publica

Volumn 29, Issue 7, 2013, Pages 1291-1300

  Ramos, Alberto Novaes ^a   Matida, Luiza Harunari ^b   Alencar, Carlos Henrique ^a   Hearst, Norman ^c   Heukelbach, Jorg ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b Secretaria de Estado da Saude de Sao Paulo   (Brazil)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Child; Delayed diagnosis; HIV

Indexed keywords

EID: 84879996000     PISSN: 0102311X     EISSN: 16784464     Source Type: Journal    
DOI: 10.1590/S0102-311X2013000700004     Document Type: Article

References (42)

1. Mofenson LM. Prevention in neglected subpopulations: prevention of mother-to-child transmission of HIV infection. Clin Infect Dis 2010; 50 Suppl 3:S130-48.
2. Brady MT, Oleske JM, Williams PL, Elgie C, Mofenson LM, Dankner WM, et al. Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era. J Acquir Immune Defic Syndr 2010; 53:86-94.
3. Dunn D, Woodburn P, Duong T, Peto J, Phillips A, Gibb D, et al. Current CD4 cell count and the shortterm risk of AIDS and death before the availability of effective antiretroviral therapy in HIV-infected children and adults. J Infect Dis 2008; 197:398-404.
4. Hazra R, Siberry GK, Mofenson LM. Growing up with HIV: children, adolescents, and young adults with perinatally acquired HIV infection. Annu Rev Med 2010; 61:169-85.
5. Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 2008; 359:2233-44.
6. Zanchetta M, Anselmi A, Vendrame D, Rampon O, Giaquinto C, Mazza A, et al. Early therapy in HIV-1-infected children: effect on HIV-1 dynamics and HIV-1-specific immune response. Antivir Ther 2008; 13:47-55.
7. Levy JA. HIV pathogenesis: 25 years of progress and persistent challenges. AIDS 2009; 23:147-60.
8. Patel K, Hernán MA, Williams PL, Seeger JD, McIntosh K, Van Dyke RB, et al. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study. Clin Infect Dis 2008; 46:507-15.
9. Ciaranello AL, Chang Y, Margulis AV, Bernstein A, Bassett IV, Losina E, et al. Effectiveness of pediatric antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis. Clin Infect Dis 2009; 49:1915-27.
10. Nunn AS, Fonseca EM, Bastos FI, Gruskin S. AIDS treatment in Brazil: impacts and challenges. Health Aff (Millwood) 2009; 28:1103-13.
11. Ramos Jr. AN, Matida LH, Hearst N, Heukelbach J. AIDS in Brazilian children: history, surveillance, antiretroviral therapy and epidemiological transition, 1984-2008. AIDS Patient Care STDS 2011; 25: 245-55.
12. STD, AIDS and Viral Hepatitis Department, Health Surveillance Secretariat, Brazilian Ministry of Health. Targets and commitments made by member-states at the United Nations General Assembly Special Session on HIV/AIDS. Brazilian response 2008-2009: country progress report. http://data. unaids.org/pub/Report/2010/brazil_2010_coun try_progress_report_en.pdf (accessed on 10/ Oct/2011).
13. Hacker MA, Kaida A, Hogg RS, Bastos FI. The first ten years: achievements and challenges of the Brazilian program of universal access to HIV/AIDS comprehensive management and care, 1996-2006. Cad Saúde Pública 2007; 23 Suppl 3:S345-59.
14. Ramos Jr. AN, Matida LH, Hearst N, Heukelbach J. Mortality in Brazilian children with HIV/AIDS: the role of non-AIDS-related conditions after highly active antiretroviral therapy introduction. AIDS Patient Care STDS 2011; 25:713-8.
15. Ramos Jr. AN, Matida LH, Hearst NG, Heukelbach J. Opportunistic illnesses in Brazilian children with AIDS: results from two national cohort studies, 1983-2007. AIDS Res Ther 2011; 8:23.
16. Ramos Jr. AN, Matida LH, Saraceni V, Veras MASM, Pontes RJS. Control of mother-to-child transmission of infectious diseases in Brazil: progress in HIV/AIDS and failure in congenital syphilis. Cad Saúde Pública 2007; 23 Suppl 3:S370-8.
17. Matida LH, Ramos Jr. AN, Heukelbach J, Sañudo A, Succi RCM, Marques HHS, et al. Improving survival in children with AIDS in Brazil: results of the second national study, 1999-2002. Cad Saúde Pública 2011; 27 Suppl 1:S93-103.
18. Souza Júnior PR, Szwarcwald CL, Castilho EA. Delay in introducing antiretroviral therapy in patients infected by HIV in Brazil, 2003-2006. Clinics 2007; 62:579-84.
19. Matida LH, Marcopito LF, Succi RC, Marques HH, Della Negra M, Grangeiro A, et al. Improving survival among Brazilian children with perinatallyacquired AIDS. Braz J Infect Dis 2004; 8:419-23.
20. Matida LH, Ramos Jr. AN, Heukelbach J, Hearst N. Continuing improvement in survival for children with acquired immunodeficiency syndrome in Brazil. Pediatr Infect Dis J 2009; 28:920-2.
21. Matida LH, Ramos Jr. AN, Moncau JEC, Marcopito LF, Marques HHS, Succi RCM, et al. AIDS by mother-to-child transmission: survival analysis of cases followed from 1983 to 2002 in different regions of Brazil. Cad Saúde Pública 2007; 23 Suppl 3: S435-44.
22. Centers for Disease Control and Prevention. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Recomm Rep 1994; 43:1-10.
23. Tess BH, Rodrigues LC, Newell ML, Dunn DT, Lago TD. Breastfeeding, genetic, obstetric and other risk factors associated with mother-to-child transmission of HIV-1 in Sao Paulo State, Brazil. AIDS 1998; 12:513-20.
24. Succi RCM; Grupo de Estudo da Sociedade Brasileira de Pediatria para Avaliar a Transmissão Materno-Infantil do HIV. Mother-to-child transmission of HIV in Brazil during the years 2000 and 2001: results of a multi-centric study. Cad Saúde Pública 2007; 23 Suppl 3:S379-89.
25. Ramos Jr. AN, Matida LH, Hearst N, Heukelbach J. AIDS morbidity and mortality in Brazilian children before and after highly active antiretroviral treatment implementation: an assessment of regional trends. Pediatr Infect Dis J 2011; 30:773-7.
26. Matida LH, Santos NJ, Ramos Jr. AN, Gianna MC, Silva MH, Domingues CS, et al. Eliminating vertical transmission of HIV in São Paulo, Brazil: progress and challenges. J Acquir Immune Defic Syndr 2011; 57 Suppl 3:S164-70.
27. Diaz C, Hanson C, Cooper ER, Read JS, Watson J, Mendez HA, et al. Disease progression in a cohort of infants with vertically acquired HIV infection observed from birth: the Women and Infants Transmission Study (WITS). J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18:221-8.
28. Goetghebuer T, Haelterman E, Le Chenadec J, Dollfus C, Gibb D, Judd A, et al. Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants. AIDS 2009; 23:597-604.
29. Newell ML, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, Dabis F, et al. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 2004; 364:1236-43.
30. Dunn D; HIV Paediatric Prognostic Markers Collaborative Study Group. Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis. Lancet 2003; 362:1605-11.
31. Boyd K, Dunn DT, Castro H, Gibb DM, Duong T, Aboulker JP, et al. Discordance between CD4 cell count and CD4 cell percentage: implications for when to start antiretroviral therapy in HIV-1 infected children. AIDS 2010; 24:1213-7.
32. Programa Nacional de DST e Aids, Secretaria de Vigilância em Saúde, Ministério da Saúde. Recomendações para terapia antirretroviral em crianças e adolescentes infectados pelo HIV: manual de bolso. Brasília: Ministério da Saúde; 2009. (Série Manuais, 85).
33. Palladino C, Bellón JM, Jarrín I, Gurbindo MD, De José MI, Ramos JT, et al. Impact of highly active antiretroviral therapy (HAART) on AIDS and death in a cohort of vertically HIV type 1-infected children: 1980-2006. AIDS Res Hum Retroviruses 2009; 25:1091-7.
34. Patel K, Hernán MA, Williams PL, Seeger JD, McIntosh K, Dyke RB, et al. Long-term effects of highly active antiretroviral therapy on CD4+ cell evolution among children and adolescents infected with HIV: 5 years and counting. Clin Infect Dis 2008; 46:1751-60.
35. Sutcliffe CG, van Dijk JH, Bolton C, Persaud D, Moss WJ. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis 2008; 8:477-89.
36. Mofenson LM, Brady MT, Danner SP, Dominguez KL, Hazra R, Handelsman E, et al. Guidelines for the prevention and treatment of opportunistic infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. MMWR Recomm Rep 2009; 58:1-166.
37. Weinberg A, Dickover R, Britto P, Hu C, Patterson-Bartlett J, Kraimer J, et al. Continuous improvement in the immune system of HIV-infected children on prolonged antiretroviral therapy. AIDS 2008; 22:2267-77.
38. Chiappini E, Galli L, Tovo PA, Gabiano C, Lisi C, Gattinara GC, et al. Changing patterns of clinical events in perinatally HIV-1-infected children during the era of HAART. AIDS 2007; 21:1607-15.
39. Ramos Jr. AN, Matida LH, Hearst N, Heukelbach J. High occurrence of HIV-positive siblings due to repeated mother-to-child-transmission in Brazil. AIDS Care 2012; 24:601-5.
40. Programa Nacional de DST e Aids, Secretaria de Vigilância em Saúde, Ministério da Saúde. Boletim Epidemiológico, Aids e DST 2009; Ano VI, n. 1.
41. Guanais FC, Macinko J. The health effects of decentralizing primary care in Brazil. Health Aff (Millwood) 2009; 28:1127-35.
42. Macinko J, Guanais FC, Fatima M, de Souza M. Evaluation of the impact of the Family Health Program on infant mortality in Brazil, 1990-2002. J Epidemiol Community Health 2006; 60:13-9.